Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
Browse Other Projects on Experiment
Related Projects
Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan
An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...
Working towards a low-cost ostomy bag that doesn't leak
Ostomy bags are a daily medical necessity for 15 million people globally. However, these bags often delaminate...
Can we find a low cost solution to store temperature sensitive enzymes in research?
Temperature-sensitive reagents are common in biology labs, and often need to be stored in expensive ultra...